In Situ Hybridization in Mouse Embryos Reveals Early Expression of AChR Subunit Genes and Rapsn in Somites and Later in Skeletal Muscle as well as in Hygroma-Relevant Regions
(A) Expression of Chrna1, Chrnb1, Chrnd, Chrng, and Rapsn in mouse development. Probes and embryonic stages are as indicated. E10.5, E11.5, and E12.5 are shown as whole-mount in situ hybridization (ISH), E14.5 and E15.5 are shown as section-ISH. Chrna1, Chrnb1, Chrnd, Chrng, and Rapsn are distinctly expressed in early somites as early as E10.5 (arrows), corresponding to human developmental age of 32 days (46 gestational day, Carnegie stage 14). At E11.5, expression of Chrna1, Chrnb1, Chrnd, Chrng, and Rapsn starts in upper developing limb and seems to further proceed from proximal into the developing muscle bulks at E12.5 days. At E14.5, expression corresponds to muscle anlagen at trunk, neck, limbs, and diaphragm. Whereas Chrna1, Chrnb1, Chrng, and Rapsn are stably expressed throughout the embryonic stages analyzed, Chrnd exhibits a more dynamic expression pattern. Chrnd shows strong expression in the posterior (newly formed) somites at E10.5 and E11.5. Expression apparently decreases around E12.5, to barely detectable levels in whole-mount and section in situ hybridization in somites (not shown). At E14.5, the muscles still show relatively weak expression. However, robust expression is reappearing in differentiated muscles at E15.5.
Comparative developmental stages adapted from Wessels and Markwald.
Mouse E10.5 ≈ Carnegie stage 14 ≈ human developmental age of 32 days (post conception) ≈ 46 days gestation (post menstruation)
Mouse E11.5 ≈ Carnegie stage 16 ≈ human developmental age of 37 days (post conception) ≈ 51 days gestation (post menstruation)
Mouse E12.5 ≈ Carnegie stage 18 ≈ human developmental age of 44 days (post conception) ≈ 58 days gestation (post menstruation)
Mouse E14.5 ≈ Carnegie stage 23 ≈ human developmental age of 54–56 days (post conception) ≈ 68–70 days gestation (post menstruation)
(B and C) Prenatal expression of AChR subunit genes and Rapsn in hygroma-relevant regions. Expression of α1 at E14.5 is representative also for β1, δ, and γ (data not shown). Note strong expression in nuchal area, close proximity to jugular lymphatic sac (marked as “jls” in higher magnification in [B]), and subcutaneous muscle layers (marked by an arrow in [C]). Mutations might contribute to edema by, for example, decreased or absent muscle contractures and subsequently impaired transport of lymphatic fluid. The lymphatic system develops from two structures. Deep parts of the jugular lymphatic sacs derive from tissue around jugular veins. Superficial parts of the jugular lymphatic sacs and peripheral lymphatic vessels develop from local lymphangioblasts originating from mesodermal anlagen. 31–34 As long as no connection is made between the jugular lymphatic sacs and the jugular veins, transient nuchal edema is physiological. If the lymphojugular junction connection is delayed and/or volume increases, abnormal nuchal edema or cystic hygroma occurs. A possible AChR-related pathomechanism for fetal edema is that defective neuromuscular signal transduction causes lack of muscle contractions and thus impairs lymphatic fluid movement. Other potential mechanisms include altered muscle development affecting subsequent development and differentiation of lymphatic vessels. Finally, both muscle and lymphatic anlagen may depend on similar AChR-related signals or components. AChR and rapsyn expression in premuscular and muscular tissues and close anatomical proximity to lymphatic structures both in embryonic development and fetal differentiation is consistent with this view.